From: Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
ISG (%)
HSG (%)
n
(Score 4)
p
(Scores 5-6)
MCT1
0.500
0.002
NT
121
17.4
66.9
T
166
18.0
46.4
MCT2
0.048
< 0.001
132
37.9
16.7
26.0
53.0
MCT4
0.474
128
16.4
7.8
168
20.8
23.2
CD147
0.211
0.153
134
11.9
41.1
167
32.9